Connect your endotoxin testing plan to the application and the decision it needs to support. Creative BioMart provides application-focused testing discussions for dialysis-related fluids, medical devices and municipal or purified water samples. Explore the services below and share the intended use, sampling context and reporting requirements to define a practical project scope.
Endotoxin testing requirements depend on how a material is used, where it is sampled and what the result needs to establish. A dialysis fluid sample, an extract from an infusion device and a municipal water sample can all be tested for bacterial endotoxin, but their preparation, specifications and interpretation differ.
An application-led review connects the sample to a defined objective: monitoring a treatment system, comparing process stages, assessing an extracted device or investigating an unexpected result. This provides a clearer starting point than choosing a method or copying a numerical limit from a different application.
Explore Endotoxin Testing by Application
Select the application that best matches your project. The focused links within each category lead to more specific sample and testing considerations.
Explore analytical support for clinically relevant materials and exposure-related questions, including dialysis water and fluid monitoring. Describe the sample, intended use and quality program so that the analytical scope can be discussed.
Focused application services: Endotoxin Testing in Dialysate — discuss testing of prepared dialysis fluid, including its composition, sample point and required quality category. Endotoxin Testing in Dialysate Water — discuss testing of treated water used to prepare dialysis fluid, with attention to the treatment stage and distribution system.
Plan testing around the device, intended contact and relevant surfaces or fluid pathways. Device geometry, materials, packaging state and extraction conditions help define what is submitted for analysis and how results should be expressed.
Focused application service: Endotoxin Testing for Infusion Devices — discuss assessment of the fluid pathway, extraction or flushing arrangements, and reporting for the defined device or assembly.
Discuss endotoxin measurements in municipal water and water samples from purification, storage or distribution systems. Identify the water grade, sampling location, treatment history and purpose of testing. Municipal supply water, purified process water and dialysis water should be evaluated within their own application context.
Projects may involve comparing source and treated water or reviewing results across defined locations and time points. The sampling plan and selected reporting range should support that question without implying that an endotoxin result alone establishes drinking-water safety or suitability for a specialized use.
Clinically relevant describes the application context. The testing discussed here supports defined analytical and quality-related projects. It does not establish a stand-alone clinical diagnosis or replace the broader assessment needed to authorize a device, fluid or water system for use.
Compare Application-Specific Testing Needs
The categories below require different information even when the analytical method is similar. Confirm the applicable specification and calculation basis before interpreting a result as acceptable or unacceptable.
On smaller screens, scroll horizontally to view all comparison columns.
Application
Material assessed
Planning priority
Reporting consideration
Dialysate
Prepared dialysis fluid at a defined sample point
Identify the fluid type, composition and required quality category
Relate EU/mL to the relevant fluid specification
Dialysis water
Treated water used in dialysis fluid preparation
Record the treatment stage, distribution location and sampling conditions
Assess against the applicable water requirement, separately from final fluid
Medical devices
An extract or rinse representing specified surfaces or pathways
Define contact, extraction conditions, device count and volume
Document conversion between extract concentration and the agreed device basis
Infusion devices
A defined device or assembly fluid pathway
Identify included components and how the pathway is sampled
State whether results represent a component, assembly or pooled preparation
Municipal and purified water
Water from an identified source, process stage or outlet
Define water grade, intended use and the monitoring or study objective
Use an application-specific target or study criterion
Choose a Testing Strategy for the Decision
A defined-threshold question may be addressed using suitable gel-clot testing. Quantitative methods can be useful when the objective includes concentration trends or comparisons across process stages. Discuss the sample properties and required reporting range before selecting an approach.
Your project objective
A useful route to discuss
Assess samples against a defined limit
Provide the specification and its basis. Review sensitivity, preparation and dilution so the test can address that limit.
Compare locations or process stages
Discuss a quantitative approach with consistent sampling, preparation and reporting units across the comparison.
Evaluate a new device or material
Review the extraction plan and test suitability together. A valid assay result does not by itself establish that extraction represents the intended device surfaces.
Investigate an unexpected increase
Provide the sampling record, handling history, controls and previous results. Distinguish an analytical issue from a possible system or process change.
Change an established test procedure
Share the existing method and purpose of the change. Define the comparison and necessary suitability work before using the revised procedure.
A laboratory result describes the material received and tested. Its usefulness for a system or product depends on how well the sample represents the question being asked. Agree on collection, extraction and handling before generating a new sample set.
Identify the sample point: record the outlet, treatment stage, fluid pathway or device surfaces represented.
Preserve context: document collection time, relevant operating conditions and the interval since cleaning or disinfection.
Define handling: discuss containers, storage, transport and holding time. Additives intended for other analyses should not be assumed suitable for endotoxin testing.
Keep the calculation traceable: retain dilution, extraction volume and device-count information where relevant.
For ongoing monitoring, consistent sample locations and handling improve the interpretability of trends. A single result may support a specific sample assessment, but it does not characterize every location or operating condition in a distribution system.
Information Needed to Plan Your Project
Application and objective
Intended use, the decision to be supported and whether the work is a sample assessment, comparison or investigation.
Sample or device details
Fluid identity and composition, water grade, or device materials, configuration and contact pathway.
Preparation and sampling
Collection point, extraction procedure, device count, volumes, dilution and any additives.
Testing requirements
Applicable specification, target reporting range, requested units and any existing method or suitability data.
Handling and schedule
Available quantity, sample count, storage conditions and proposed shipment and completion dates.
Our team reviews these details to discuss a feasible scope and quotation. Additional preparation, method assessment and documentation are defined for the project rather than assumed from the application name.
How do I choose between the application service pages?
Choose the page matching the material and its intended use. For example, select dialysis water for treated water used in fluid preparation and dialysate for the prepared fluid. If the project covers several categories, describe the complete scope in one enquiry.
Are dialysis water and dialysate evaluated against the same requirements?
Not automatically. Water used to prepare dialysis fluid and the final dialysis fluid are distinct materials. The relevant requirements also depend on the therapy and fluid quality category. State the material and applicable specification when requesting testing.
Does clinically relevant testing include patient diagnosis?
The service entry addresses analytical work in a clinically relevant application context. It does not establish a diagnostic service or authorize clinical interpretation. Describe the intended use so the proposed analytical work and its limits are clear.
Is there one endotoxin limit for every medical device?
No. The relevant limit depends on intended contact and applicable product requirements. Provide the device use and specification rather than applying a value from another device or assuming all tissue contacts are equivalent.
Can an extract result in EU/mL be reported directly as EU/device?
No. The calculation needs the defined extraction volume, number of devices and any analytical dilution correction. For pooled extractions, a per-device calculation does not establish the individual value for every unit. Agree on the reporting basis before testing.
Does sterilization eliminate the need to consider endotoxin?
No. Microbial inactivation and endotoxin reduction are different objectives. A sterilization claim alone does not demonstrate endotoxin removal, and an acceptable endotoxin result does not establish sterility.
Can municipal water results be interpreted using a dialysis water limit?
Not simply because both samples are water. Intended use determines the relevant assessment framework. A dialysis water requirement should not be treated as a universal municipal water criterion or a complete assessment of drinking-water safety.
Can one endotoxin result establish that a system or device is safe to use?
No. The result addresses bacterial endotoxin in the tested preparation under the stated conditions. System or product decisions may also require chemical, microbiological, material-related or other evidence, together with an appropriate sampling and quality program.
Discuss Your Application and Testing Requirements
Send us the intended use, sample or device details and the question your testing needs to answer. Our team will discuss the analytical scope, sample requirements and reporting approach.
International Organization for Standardization. ISO 23500-3:2024. Preparation and quality management of fluids for haemodialysis and related therapies — Part 3: Water for haemodialysis and related therapies.
International Organization for Standardization. ISO 23500-5:2024. Preparation and quality management of fluids for haemodialysis and related therapies — Part 5: Quality of dialysis fluid for haemodialysis and related therapies.
International Organization for Standardization. ISO 11737-3:2023. Sterilization of health care products — Microbiological methods — Part 3: Bacterial endotoxin testing.
United States Pharmacopeia. General Chapter <85>: Bacterial Endotoxins Test.
